Thrombin Generation is Associated With CA 19-9 In Vitro and in Pancreatic Ductal Adenocarcinoma

被引：0
|
作者：
Mattila, N. [1 ,2 ,3 ]
Przybyla, B. [2 ,3 ]
Seppanen, H. [1 ,2 ]
Haglund, C. [1 ,2 ,4 ]
Lassila, R. [2 ,3 ,5 ]
机构：
[1] Univ Helsinki, Dept Surg, Helsinki, Finland
[2] Helsinki Univ Hosp, Helsinki, Finland
[3] Univ Helsinki, Dept Hematol, Coagulat Disorders Unit, Ctr Comprehens Canc, Helsinki, Finland
[4] Univ Helsinki, Res Programs Unit, Translat Canc Biol, Helsinki, Finland
[5] HUSLAB Lab Serv, Clin Chem, Helsinki, Finland
来源：
PANCREAS | 2018年 / 47卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1409 / 1409
页数：1
相关论文
共 50 条
  • [1] Clinical Outcomes Associated with CA 19-9 Dynamics during Chemoradiation in Unresectable Pancreatic Ductal Adenocarcinoma
    Mao, S.
    Oruganti, S. B.
    Lin, T. A.
    Sehgal, S.
    Reddy, A. V.
    Narang, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E468 - E469
  • [2] Combining sCD163 with CA 19-9 Increases the Predictiveness of Pancreatic Ductal Adenocarcinoma
    Stuhr, Liva K. K.
    Madsen, Kasper
    Johansen, Astrid Z. Z.
    Chen, Inna M. M.
    Hansen, Carsten P. P.
    Jensen, Lars H. H.
    Hansen, Torben F. F.
    Klove-Mogensen, Kirstine
    Nielsen, Kaspar R. R.
    Johansen, Julia S. S.
    CANCERS, 2023, 15 (03)
  • [3] CA 19-9 Normalization Following Neoadjuvant Therapy and Yield of Laparoscopy for Pancreatic Ductal Adenocarcinoma
    Fields, Brittany C.
    Vreeland, Tim
    Newhook, Timpthy E.
    Snyder, Rebecca A.
    Maxwell, Jessica E.
    Prakash, Laura R.
    Kim, Michael
    Ikoma, Naruhiko
    Lee, Jeffrey E.
    Katz, Matthew H. G.
    Tzeng, Ching-Wei D.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S63 - S64
  • [4] CA 19-9 as a predictor of TNM stage for pancreatic adenocarcinoma
    Kowalski, T
    Loren, D
    Raza, A
    Setty, S
    Rosato, E
    GASTROENTEROLOGY, 2004, 126 (04) : A30 - A30
  • [5] Differential impact of incrementally elevated CA 19-9 levels on prognosis of resected pancreatic ductal adenocarcinoma
    Bhandare, Manish S.
    Gupta, Vikas
    Chaudhari, Vikram
    Nandy, Kunal
    Ostwal, Vikas
    Ramaswamy, Anant
    Nashikkar, Chaitali
    Engineer, Reena
    Krishnatry, Rahul
    Shrikhande, Shailesh V.
    HPB, 2024, 26 (10) : 1237 - 1247
  • [6] Serum CA 19-9 Response to Neoadjuvant Therapy is Associated with Outcome in Pancreatic Adenocarcinoma
    Brian A. Boone
    Jennifer Steve
    Mazen S. Zenati
    Melissa E. Hogg
    Aatur D. Singhi
    David L. Bartlett
    Amer H. Zureikat
    Nathan Bahary
    Herbert J. Zeh
    Annals of Surgical Oncology, 2014, 21 : 4351 - 4358
  • [7] CA 19-9 Nonproduction Is Associated With Poor Survival After Resection of Pancreatic Adenocarcinoma
    Hayman, Amanda V.
    Stocker, Susan J.
    Baker, Marshall S.
    Bentrem, David J.
    Prinz, Richard A.
    Marsh, Robert de W.
    Talamonti, Mark S.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (06): : 550 - 554
  • [8] Serum CA 19-9 Response to Neoadjuvant Therapy is Associated with Outcome in Pancreatic Adenocarcinoma
    Boone, Brian A.
    Steve, Jennifer
    Zenati, Mazen S.
    Hogg, Melissa E.
    Singhi, Aatur D.
    Bartlett, David L.
    Zureikat, Amer H.
    Bahary, Nathan
    Zeh, Herbert J., III
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (13) : 4351 - 4358
  • [9] CA 19-9 and survival in advanced and unresectable pancreatic adenocarcinoma and cholangiocarcinoma
    Ali C.W.
    Kaye T.F.
    Adamson D.J.A.
    Tait I.S.
    Polignano F.M.
    Highley M.S.
    Journal of Gastrointestinal Cancer, 2007, 38 (2-4) : 108 - 114
  • [10] Prognostic value of CA 19-9 level in resectable pancreatic adenocarcinoma
    Rudnicki, J.
    Agrawal, A. K.
    Grzebieniak, Z.
    Zukrowski, P.
    Zysko, D.
    Jelen, M.
    Kielan, W.
    Sebastian, M.
    Slonina, J.
    Marek, G.
    Duda-Barcik, L.
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2010, 48 (02) : 249 - 261
12345